<DOC>
	<DOCNO>NCT00984867</DOCNO>
	<brief_summary>This study aim investigate dapagliflozin control blood sugar patient type 2 diabetes add exist treatment ( sitagliptin alone combination metformin ) . The effect dapagliflozin weight blood pressure also study .</brief_summary>
	<brief_title>Dapagliflozin DPPIV Inhibitor add-on Study</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients type 2 diabetes Patients receive treatment , currently receive metformin , sitagliptin vildagliptin combination Patients screen blood test need additional therapy enrol Patients type 1 diabetes Patients poorly control diabetes Any clinically significant illness , judgement investigator would compromise patient 's safety successful participation clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Dapagliflozin DPP IV inhibitor add study</keyword>
	<keyword>Inadequate control</keyword>
</DOC>